- Report
- October 2023
- 185 Pages
Global
From €4729EUR$4,900USD£4,057GBP
- Report
- October 2023
- 145 Pages
Global
From €3040EUR$3,150USD£2,608GBP
- Report
- March 2024
- 65 Pages
Europe
From €3330EUR$3,450USD£2,856GBP
- Report
- April 2021
- 269 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Report
- June 2019
- 114 Pages
Global
From €10612EUR$10,995USD£9,103GBP
- Report
- March 2024
- 60 Pages
From €2847EUR$2,950USD£2,442GBP
- Webinar
- August 2022
- 60 Minutes
Global
From €188EUR$195USD£161GBP
- Webinar
- August 2018
- 60 Minutes
Global
From €173EUR$179USD£148GBP
- Webinar
- June 2018
- 90 Minutes
Global
From €173EUR$179USD£148GBP
- Book
- May 2018
- 872 Pages
- Book
- August 2013
- 462 Pages
Global
Attention Deficit Disorder (ADD) is a mental health disorder characterized by difficulty focusing, impulsivity, and hyperactivity. It is most commonly diagnosed in children, but can also affect adults. Symptoms of ADD can include difficulty paying attention, difficulty organizing tasks, restlessness, and impulsivity. Treatment for ADD typically includes medication, psychotherapy, and lifestyle changes.
The Attention Deficit Disorder market is a subset of the larger Mental Health market. It is a growing market, with an increasing number of people seeking treatment for ADD. The market is expected to continue to grow as more people become aware of the disorder and seek treatment.
Companies in the Attention Deficit Disorder market include Shire Pharmaceuticals, Novartis, and Eli Lilly. Other companies in the Mental Health market include Pfizer, Johnson & Johnson, and GlaxoSmithKline. Show Less Read more